Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKN1 | Q16512 | 3/20 | 0.77 |
| ▸ | PKN2 | Q16513 | 3/20 | 0.77 |
| ▸ | PLK4 | O00444 | 1/20 | 0.77 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.77 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.77 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.77 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.77 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.77 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.77 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.77 |
| ▸ | PIM1 | P11309 | 1/20 | 0.77 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.77 |
| ▸ | PRKACA | P17612 | 1/20 | 0.77 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.77 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.77 |
| ▸ | CLK2 | P49760 | 1/20 | 0.77 |
| ▸ | GSK3A | P49840 | 1/20 | 0.77 |
| ▸ | PRKX | P51817 | 1/20 | 0.77 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.77 |
| ▸ | STK3 | Q13188 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL656979 | 0.90 | PKN1 (0.78) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL6809991 | 0.87 | PKN1 (1.00) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL657126 | 0.85 | PKN1 (0.58) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL657620 | 0.84 | PKN1 (0.60) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL660169 | 0.83 | PARP1 (0.71) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL657761 | 0.82 | PARP1 (0.60) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL656906 | 0.81 | PKN1 (0.73) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL657327 | 0.81 | PARP1 (0.55) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL2293271 | 0.81 | PARP1 (0.57) | PKN1PKN2PLK4MAPK13DYRK3 | |
| SCHEMBL29412126 | 0.80 | PKN1 (0.64) | PKN1PKN2PLK4MAPK13DYRK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046303-A1 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2012-02-23 | — | — | US | claimed |
| EP-2183248-A2 | BENZIMIDAZOLE POLY (ADP RIBOSE) POLYMERASE INHIBITORS | Abbott Laboratories (US) | 2010-05-12 | — | — | EP | claimed |
| US-20090030016-A1 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2009-01-29 | — | — | US | claimed |
| WO-2009012280-A2 | BENZIMIDAZOLE POLY(ADP-RIBOSE)POLYMERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2009-01-22 | — | — | WO | claimed |
| US-20120046303-A1 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2012-02-23 | — | — | US | disclosed |
| US-8067613-B2 | Benzimidazole poly(ADP ribose)polymerase inhibitors | ABBOTT LABORATORIES (US) | 2011-11-29 | — | — | US | disclosed |
| EP-2183248-A2 | BENZIMIDAZOLE POLY (ADP RIBOSE) POLYMERASE INHIBITORS | Abbott Laboratories (US) | 2010-05-12 | — | — | EP | disclosed |
| US-20090030016-A1 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2009-01-29 | — | — | US | disclosed |
| WO-2009012280-A2 | BENZIMIDAZOLE POLY(ADP-RIBOSE)POLYMERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2009-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030016-A1 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | PARP1, PARP2, PARP3 | PKN1 1633/4885PKN2 1282/4885PLK4 804/4885 |
| US-20120046303-A1 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | PARP1, PARP2, PARP3 | PKN1 1633/4885PKN2 1282/4885PLK4 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.